Corcept Therapeutics Incorporated
corporate_fare Company Profile
Corcept Therapeutics Incorporated (NASDAQ:CORT) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 25 items for CORT at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Corcept Therapeutics Incorporated Securities Fraud Class Action Result of FDA Approval Issues and 50% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
- Corcept Therapeutics Faces Major Setbacks: FDA Rejects Relacorilant, Key Patent Lost, and Profitability Declines
- Corcept Reports Mixed 2025 Results, Sets PDUFA for Ovarian Cancer Drug, Advances ALS & MASH Pipeline
- Corcept Loses Federal Circuit Patent Appeal Against Teva for Key Drug Korlym
- Corcept's Phase 3 ROSELLA Trial Meets Overall Survival Endpoint in Platinum-Resistant Ovarian Cancer
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$761.41M
Net Income
$99.65M
Diluted EPS
$0.82
Op. Cash Flow
$142M
Free Cash Flow
$141.78M
Gross Profit
$748.43M
Operating Income
$44.8M
Cash & Equivalents
$120.5M
Debt / Equity
0.00×
Net Margin
13.1%
Shares Outstanding
105.97M sh
Source: 10-K · filed 2026-02-24 · accession 0001628280-26-011091
show_chartPrice Chart
Loading chart...
feed CORT - Filings & News (Page 2)
CORT
Feb 26, 2026, 9:25 PM EST
Price at Filing:
$35.78
Real-time Price:
$63.62
Change:
+$27.84 (+78%)
Market Cap:
$6.963B
CORT
Feb 24, 2026, 4:13 PM EST
Price at Filing:
$35.10
Real-time Price:
$63.62
Change:
+$28.52 (+81%)
Market Cap:
$6.963B
CORT
Feb 24, 2026, 4:10 PM EST
Corcept Reports Mixed 2025 Results, Sets PDUFA for Ovarian Cancer Drug, Advances ALS & MASH Pipeline
Price at Filing:
$35.10
Real-time Price:
$63.62
Change:
+$28.52 (+81%)
Market Cap:
$6.963B
CORT
Feb 19, 2026, 4:38 PM EST
Price at Filing:
$33.56
Real-time Price:
$63.62
Change:
+$30.06 (+90%)
Market Cap:
$6.963B
CORT
Jan 22, 2026, 8:10 AM EST
Corcept's Phase 3 ROSELLA Trial Meets Overall Survival Endpoint in Platinum-Resistant Ovarian Cancer
Price at Filing:
$45.00
Real-time Price:
$63.62
Change:
+$18.62 (+41%)
Market Cap:
$6.963B